JP2020531486A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531486A5
JP2020531486A5 JP2020510096A JP2020510096A JP2020531486A5 JP 2020531486 A5 JP2020531486 A5 JP 2020531486A5 JP 2020510096 A JP2020510096 A JP 2020510096A JP 2020510096 A JP2020510096 A JP 2020510096A JP 2020531486 A5 JP2020531486 A5 JP 2020531486A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020510096A
Other languages
Japanese (ja)
Other versions
JP7199737B2 (ja
JP2020531486A (ja
JPWO2019038387A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/072788 external-priority patent/WO2019038387A1/en
Publication of JP2020531486A publication Critical patent/JP2020531486A/ja
Publication of JP2020531486A5 publication Critical patent/JP2020531486A5/ja
Publication of JPWO2019038387A5 publication Critical patent/JPWO2019038387A5/ja
Priority to JP2022198540A priority Critical patent/JP2023021276A/ja
Application granted granted Critical
Publication of JP7199737B2 publication Critical patent/JP7199737B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020510096A 2017-08-23 2018-08-23 ピリジルピリドン化合物 Active JP7199737B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022198540A JP2023021276A (ja) 2017-08-23 2022-12-13 ピリジルピリドン化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17187544.6 2017-08-23
EP17187544 2017-08-23
PCT/EP2018/072788 WO2019038387A1 (en) 2017-08-23 2018-08-23 PYRIDYLPYRIDONE COMPOUNDS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022198540A Division JP2023021276A (ja) 2017-08-23 2022-12-13 ピリジルピリドン化合物

Publications (4)

Publication Number Publication Date
JP2020531486A JP2020531486A (ja) 2020-11-05
JP2020531486A5 true JP2020531486A5 (https=) 2022-10-20
JPWO2019038387A5 JPWO2019038387A5 (https=) 2022-10-20
JP7199737B2 JP7199737B2 (ja) 2023-01-06

Family

ID=59686881

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020510096A Active JP7199737B2 (ja) 2017-08-23 2018-08-23 ピリジルピリドン化合物
JP2022198540A Pending JP2023021276A (ja) 2017-08-23 2022-12-13 ピリジルピリドン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022198540A Pending JP2023021276A (ja) 2017-08-23 2022-12-13 ピリジルピリドン化合物

Country Status (20)

Country Link
US (2) US11219618B2 (https=)
EP (2) EP4056556A1 (https=)
JP (2) JP7199737B2 (https=)
KR (1) KR102730718B1 (https=)
CN (3) CN111094244B (https=)
AU (2) AU2018320416B2 (https=)
CY (1) CY1125138T1 (https=)
DK (1) DK3672941T3 (https=)
ES (1) ES2910839T3 (https=)
HR (1) HRP20220571T1 (https=)
HU (1) HUE058977T2 (https=)
IL (3) IL302356A (https=)
LT (1) LT3672941T (https=)
PL (1) PL3672941T3 (https=)
PT (1) PT3672941T (https=)
RS (1) RS63161B1 (https=)
SI (1) SI3672941T1 (https=)
SM (1) SMT202200183T1 (https=)
TW (2) TW202308996A (https=)
WO (1) WO2019038387A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020012651A2 (pt) 2017-12-22 2020-12-01 Ravenna Pharmaceuticals, Inc. compostos derivados de aril-bipiridina amina como inibidores da fosfatidilinositol fosfato quinase, composição farmacêutica compreendendo os mesmos e usos terapêuticos dos ditos compostos
CA3199988A1 (en) 2020-11-25 2022-06-02 Daniel L. Flynn Pyridylpyridone derivatives as vsp34 inhibitors for use in the treatment of a viral infection
WO2022115562A1 (en) 2020-11-25 2022-06-02 Deciphera Pharmaceuticals, Llc Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection
AU2022326573A1 (en) * 2021-08-13 2024-02-15 Deciphera Pharmaceuticals, Llc Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2485166A1 (en) * 2002-05-21 2003-12-04 Amgen Inc. Substituted pyrimidinone and pyridinone compounds
TW200908984A (en) * 2007-08-07 2009-03-01 Piramal Life Sciences Ltd Pyridyl derivatives, their preparation and use
AU2011346567A1 (en) * 2010-12-21 2013-07-25 Novartis Ag Bi-heteroaryl compounds as Vps34 inhibitors
DK2655375T3 (en) 2010-12-23 2015-03-09 Sanofi Sa PYRIMIDINON DERIVATIVES, PREPARATION AND PHARMACEUTICAL USE THEREOF
GB201120317D0 (en) 2011-11-24 2012-01-04 Queen Mary & Westfield College Screening method
HUE053994T2 (hu) * 2012-03-01 2021-08-30 Array Biopharma Inc Szerin/treonin kináz inhibitorok
JP6215315B2 (ja) * 2012-06-12 2017-10-18 アッヴィ・インコーポレイテッド ピリジノンおよびピリダジノン誘導体
FR2992314B1 (fr) 2012-06-22 2015-10-16 Sanofi Sa Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique
WO2015108881A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
AU2015206652A1 (en) 2014-01-14 2016-08-04 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
WO2016001789A1 (en) 2014-06-30 2016-01-07 Pfizer Inc. Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer
AU2017219846B2 (en) 2016-02-19 2021-05-13 Sprint Bioscience Ab 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes
DK3416957T3 (da) 2016-02-19 2020-09-21 Sprint Bioscience Ab 6-heterocyclyl-4-morpholin-4-ylpyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes

Similar Documents

Publication Publication Date Title
BR122022006221A2 (https=)
BR122022015534A2 (https=)
AT524834A2 (https=)
JP2020531486A5 (https=)
BR122022016585A2 (https=)
BR212020012832U2 (https=)
BR202018071071U8 (https=)
BR202018008879U2 (https=)
BR202018007669U2 (https=)
BR202018006247U2 (https=)
BR202018004136U2 (https=)
BR202018002487U2 (https=)
BR202018002069U2 (https=)
CN304434110S (https=)
CN304388867S9 (https=)
CN304438959S (https=)
CN304437214S (https=)
CN304436080S (https=)
CN304434447S (https=)
CN304434154S (https=)
CN304434153S (https=)
CN304434112S (https=)
CN304442425S (https=)
CN303584708S8 (https=)
CN304434101S (https=)